Twitter Logo Youtube Circle Icon LinkedIn Icon

The Legal 500 Hall of Fame Icon The Legal 500 Hall of Fame highlights individuals who have received constant praise by their clients for continued excellence. The Hall of Fame highlights, to clients, the law firm partners who are at the pinnacle of the profession. In Europe, Middle East and Africa, the criteria for entry is to have been recognised by The Legal 500 as one of the elite leading lawyers for seven consecutive years. These partners are highlighted below and throughout the editorial.
Click here for more details

Israel > Healthcare and life sciences > Law firm and leading lawyer rankings

Editorial

Index of tables

  1. Healthcare and life sciences
  2. Leading individuals

Leading individuals

  1. 1

Who Represents Who

Find out which law firms are representing which Healthcare and life sciences clients in Israel using The Legal 500's new comprehensive database of law firm/client relationships. Instantly search over 925,000 relationships, including over 83,000 Fortune 500, 46,000 FTSE350 and 13,000 DAX 30 relationships globally. Access is free for in-house lawyers, and by subscription for law firms. For more information, contact david.burgess@legal500.com.

CLICK HERE TO VISIT THE WHO REPRESENTS WHO SITE

Goldfarb Seligman & Co.’s healthcare and life sciences team advises domestic and international biotech and pharmaceutical companies on complex commercial agreements and strategic financing and M&A transactions. Led by Eli Zohar, the team serves as outside counsel to The Israeli Medical Association. Sharon Gazit assists foreign medical device companies with operations in Israel.

As one of Israel’s two largest firms, Herzog Fox & Neeman’s broad healthcare and life sciences department acts for a variety of healthcare-focused corporates, pharmaceutical companies, investors and physicians. Zohar Yahalom has a formidable regulatory practice, while Dan Sharot and Neta Dorfman Raviv handle commercial and partnership agreements and financing transactions.

Acting for corporates and sector-specific investors, Horn & Co has a strong reputation in the Israeli life sciences and pharmaceuticals industry. Yuval Horn has considerable experience in cross-border commercial contracts, partnership agreements, financing and M&A. Horn also represents Pontifax in all of its investment activity. Keren Kanir and Ohad Mamann are additional contacts.

Liad Whatstein & Co. Law Office demonstrates ‘broad business acumen and industry knowledge of the pharmaceutical sector in Israel and further afield’. Led by Liad Whatstein, the firm’s reputation is evinced by an impressive client roster, which includes Novartis, Sanofi, Merck, Pfizer, Eli Lilly and the State of Israel. Amira Mangelus is also recommended.

Lipa Meir & Co provides comprehensive commercial and regulatory advice to healthcare providers, medical device manufacturers and distributors, private medical centres and tech companies. Osnat Sarusi-Firstater acts for pioneering med-tech companies such as Opisoft and Circ MedTech, while Gary Copelovitz is instructed by health services giant Clalit Health Services.

M. Firon & Co Advocates and Notaries is considered by many to be ‘the best firm in Israel for pharmaceutical’ companies. Indeed, Baruch Shugol provides commercial and regulatory advice to GSK Israel and Pfizer Israel, while Niv Sever acts for Sanofi Aventis Israel and Gilead. Liora Lotenberg took an in-house position with one of the firm’s clients.

S. Horowitz & Co’s healthcare capabilities are wide ranging, covering the gamut of corporate transactions and commercial agreements, litigation and regulatory and legislative counselling, particularly in the pharmaceutical sector. Headed by Tal Band and Dovev Apel, the department acts for Teva, Maccabi Healthcare Services and The Chemical, Pharmaceutical and Environmental Society of the Manufacturers’ Association of Israel.

The team at Tadmor & Co. Yuval Levy & Co. ‘exemplifies healthcare sector expertise’ and works with hospitals, industry associations, healthcare and pharmaceutical companies, and state-sponsored incubators. Efrat Shapira-Orren heads the department and Efrat Cohen assisted SAREL Supplies & Services for Medicine in governmental proceedings regarding services provided to the state healthcare system.

Yigal Arnon & Co is involved in many of the largest cross-border M&A in Israel’s healthcare sector. Daniel Green advises Oramed Pharmaceuticals on commercial licensing transactions and cross-border partnership agreements. Yoheved Novogroder-Shoshan and Barry Levenfeld act for biotech incubators such as FutuRx and MEDX Xelerator.

Amit, Pollak, Matalon & Co. Advocates and Notary acts for biotech start-ups, listed healthcare companies, sector-specific investors and healthcare incubators. Practice head Ian Rostowsky advised MindUp on its bid for and activation of a franchise from the Israeli National Authority for Technological Innovation.

At Barath, Pappo, Betser, Floom, Schrieber & Co. (BFP & Co.), Haleli Barath advises biotech companies on development, licensing and partnership agreements and corporate finance transactions. The team acts for industry investors such as Triventures and eHealth Ventures.

Fischer Behar Chen Well Orion & Co has extensive experience advising investment groups and Israeli hi-tech companies on financing and securities transactions. Eran Yaniv assisted MetaboMed with equity investment rounds with sophisticated investors. Raz Tepper advises investor clients.

GKH – Gross, Kleinhendler, Hodak, Halevy, Greenberg & Co handles large financing, M&A and capital markets transactions for funds and major healthcare companies, including Edwards Lifesciences. Hili Cohen advised biotech incubators on an Israeli Innovation Authority tender for government sponsorship.

The ‘responsive and professional’ department at Katzenell Dimant has ‘excellent knowledge of the healthcare sector’ and is ‘well connected to industry players domestically and globally’. Einat Katzenell’s team advises biotech companies and sector-specific investors on commercial agreements, various corporate transactions and regulatory compliance.

Meitar Liquornik Geva Leshem Tal Law Offices is instructed by biotech, pharmaceutical and medical device companies in corporate transactions and litigation. Israel Leshem and Ron Peleg have handled high-value disputes for AstraZeneca, while David Mirchin handles commercial agreements for the client.

Pearl Cohen Zedek Latzer Baratz handles a range of IP, commercial and corporate transactional work for listed biotech companies. Hili Rashkovan has experience in global clinical trial arrangements, and Mark Cohen handles licensing and rights transactions for Immune Pharmaceuticals.

Shibolet & Co. with Raved, Magriso, Benkel & Co. advises Israeli medical companies on partnership and R&D agreements with multinational healthcare companies and also handles multijurisdictional transactions. Ofer Ben-Yehuda has assisted biotech companies involved in cross-border clinical trials. Tal Karplus and Amir Iliescu are other contacts. The legacy Shibolet firm merged with Raved, Magriso, Benkel & Co. at the end of 2017.

Press releases

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to

Legal Developments in Israel

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

Press Releases worldwide

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to